FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2108744304> ?p ?o ?g. }

• W2108744304 endingPage "e88854" @default.
• W2108744304 startingPage "e88854" @default.
• W2108744304 abstract "Background Using surrogate biomarkers for disease progression as endpoints in neuroprotective clinical trials may help differentiate symptomatic effects of potential neuroprotective agents from true slowing of the neurodegenerative process. A systematic review was undertaken to determine what biomarkers for disease progression in Alzheimer's disease exist and how well they perform. Methods MEDLINE and Embase (1950–2011) were searched using five search strategies. Abstracts were assessed to identify papers meriting review in full. Studies of participants with probable Alzheimer's disease diagnosed by formal criteria were included. We made no restriction on age, disease duration, or drug treatment. We only included studies with a longitudinal design, in which the putative biomarker and clinical measure were both measured at least twice, as this is the only appropriate study design to use when developing a disease progression biomarker. We included studies which attempted to draw associations between the changes over time in the biomarker used to investigate disease progression and a clinical measure of disease progression. Results Fifty-nine studies were finally included. The commonest biomarker modality examined was brain MRI (17/59, 29% of included studies). Median follow-up in included studies was only 1.0 (IQR 0.8–1.7) year and most studies only measured the putative biomarker and clinical measure twice. Included studies were generally of poor quality with small numbers of participants (median 31 (IQR 17 to 64)), applied excessively restrictive study entry criteria, had flawed methodologies and conducted overly simplistic statistical analyses without adjusting for confounding factors. Conclusions We found insufficient evidence to recommend the use of any biomarker as an outcome measure for disease progression in Alzheimer's disease trials. However, further investigation into the efficacy of using MRI measurements of ventricular volume and whole brain volume appeared to be merited. A provisional ‘roadmap’ to improve the quality of future disease progression biomarker studies is presented." @default.
• W2108744304 created "2016-06-24" @default.
• W2108744304 creator A5033361414 @default.
• W2108744304 creator A5041016511 @default.
• W2108744304 creator A5064853539 @default.
• W2108744304 creator A5072511800 @default.
• W2108744304 creator A5073259686 @default.
• W2108744304 creator A5083154337 @default.
• W2108744304 date "2014-02-18" @default.
• W2108744304 modified "2023-10-10" @default.
• W2108744304 title "A Systematic Review of Biomarkers for Disease Progression in Alzheimer's Disease" @default.
• W2108744304 cites W1554272019 @default.
• W2108744304 cites W1968551454 @default.
• W2108744304 cites W1996124217 @default.
• W2108744304 cites W2002123847 @default.
• W2108744304 cites W2024719735 @default.
• W2108744304 cites W2065854793 @default.
• W2108744304 cites W2072572621 @default.
• W2108744304 cites W2080736230 @default.
• W2108744304 cites W2103514611 @default.
• W2108744304 cites W2106931873 @default.
• W2108744304 cites W2137070022 @default.
• W2108744304 cites W2146729934 @default.
• W2108744304 cites W2150839822 @default.
• W2108744304 cites W2156220037 @default.
• W2108744304 cites W2159529587 @default.
• W2108744304 cites W2168516263 @default.
• W2108744304 cites W2169233645 @default.
• W2108744304 cites W2511246053 @default.
• W2108744304 cites W2725718031 @default.
• W2108744304 cites W91108901 @default.
• W2108744304 doi "https://doi.org/10.1371/journal.pone.0088854" @default.
• W2108744304 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3928315" @default.
• W2108744304 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24558437" @default.
• W2108744304 hasPublicationYear "2014" @default.
• W2108744304 type Work @default.
• W2108744304 sameAs 2108744304 @default.
• W2108744304 citedByCount "41" @default.
• W2108744304 countsByYear W21087443042014 @default.
• W2108744304 countsByYear W21087443042015 @default.
• W2108744304 countsByYear W21087443042016 @default.
• W2108744304 countsByYear W21087443042017 @default.
• W2108744304 countsByYear W21087443042018 @default.
• W2108744304 countsByYear W21087443042019 @default.
• W2108744304 countsByYear W21087443042020 @default.
• W2108744304 countsByYear W21087443042021 @default.
• W2108744304 countsByYear W21087443042022 @default.
• W2108744304 countsByYear W21087443042023 @default.
• W2108744304 crossrefType "journal-article" @default.
• W2108744304 hasAuthorship W2108744304A5033361414 @default.
• W2108744304 hasAuthorship W2108744304A5041016511 @default.
• W2108744304 hasAuthorship W2108744304A5064853539 @default.
• W2108744304 hasAuthorship W2108744304A5072511800 @default.
• W2108744304 hasAuthorship W2108744304A5073259686 @default.
• W2108744304 hasAuthorship W2108744304A5083154337 @default.
• W2108744304 hasBestOaLocation W21087443041 @default.
• W2108744304 hasConcept C126322002 @default.
• W2108744304 hasConcept C141341695 @default.
• W2108744304 hasConcept C143998085 @default.
• W2108744304 hasConcept C148482608 @default.
• W2108744304 hasConcept C2779134260 @default.
• W2108744304 hasConcept C2781197716 @default.
• W2108744304 hasConcept C502032728 @default.
• W2108744304 hasConcept C535046627 @default.
• W2108744304 hasConcept C55493867 @default.
• W2108744304 hasConcept C60644358 @default.
• W2108744304 hasConcept C71924100 @default.
• W2108744304 hasConcept C77350462 @default.
• W2108744304 hasConcept C86803240 @default.
• W2108744304 hasConcept C95190672 @default.
• W2108744304 hasConceptScore W2108744304C126322002 @default.
• W2108744304 hasConceptScore W2108744304C141341695 @default.
• W2108744304 hasConceptScore W2108744304C143998085 @default.
• W2108744304 hasConceptScore W2108744304C148482608 @default.
• W2108744304 hasConceptScore W2108744304C2779134260 @default.
• W2108744304 hasConceptScore W2108744304C2781197716 @default.
• W2108744304 hasConceptScore W2108744304C502032728 @default.
• W2108744304 hasConceptScore W2108744304C535046627 @default.
• W2108744304 hasConceptScore W2108744304C55493867 @default.
• W2108744304 hasConceptScore W2108744304C60644358 @default.
• W2108744304 hasConceptScore W2108744304C71924100 @default.
• W2108744304 hasConceptScore W2108744304C77350462 @default.
• W2108744304 hasConceptScore W2108744304C86803240 @default.
• W2108744304 hasConceptScore W2108744304C95190672 @default.
• W2108744304 hasIssue "2" @default.
• W2108744304 hasLocation W21087443041 @default.
• W2108744304 hasLocation W21087443042 @default.
• W2108744304 hasLocation W21087443043 @default.
• W2108744304 hasLocation W21087443044 @default.
• W2108744304 hasLocation W21087443045 @default.
• W2108744304 hasLocation W21087443046 @default.
• W2108744304 hasOpenAccess W2108744304 @default.
• W2108744304 hasPrimaryLocation W21087443041 @default.
• W2108744304 hasRelatedWork W1992228662 @default.
• W2108744304 hasRelatedWork W2026939478 @default.
• W2108744304 hasRelatedWork W2052913503 @default.
• W2108744304 hasRelatedWork W2066002429 @default.
• W2108744304 hasRelatedWork W2481749367 @default.

• next